Social network
Investors - Ensuring sustainable growth
Investors - Ensuring sustainable growth

Investors

Ensuring sustainable growth

Tools content (print, share, increase/decrease text size):

Investors - Ensuring sustainable growth

 

Middle area

June 16, 2014

Q1 2017 Results

April 28, 2017

First quarter results 2017

Results will be reviewed by management at a conference call with the financial community.

Dupixent approval

March 28, 2017

Dupixent® FDA approval call

Sanofi and Regeneron hosted a conference call following the approval of Dupixent® in the United States.

Broker Conference

March 07, 2017

Cowen Healthcare Conference

Presentation by Bill Sibold, Global Franchise Head of Multiple Sclerosis, Oncology and Immunology, Sanofi Genzyme.

Broker Conference

February 16, 2017

Leerink 6th Healthcare Summit

Presentation by David Meeker, Executive Vice President and General Manager of Sanofi Genzyme

Q4 and Full Year 2016 Results

February 08, 2017

Q4 and Full Year 2016 Results

Results were reviewed by management at a conference call with the financial community.

 

     

    Upcoming events

    April 28, 2017

    • First quarter results 2017  
      7:30 am CEST / 1:30 am EDT: Press release
      2:30 pm CEST / 8:30 am EDT: Live audio webcast of the conference call   
     

    May 04, 2017

     

    May 10, 2017

       

    Right area:

    Stock Market

    IR mobile application

    SANOFI IR - The Investor Relations Mobile Application

    SANOFI IR is available on iPhone, iPad, Apple Watch and Android!
    NEW - Section dedicated to Individual Shareholders

     
     

    © Sanofi 2004-2017 - All rights reserved - Update: November 29, 2016

    • Site complies with W3C WCAG 2.0 (new window, in english)